These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37222607)

  • 1. Coding-Complete Genome Sequences of an Omicron Subvariant (BA.5.2.20) of SARS-CoV-2.
    Rhazzar Z; Hemlali M; Melloul M; Ouarab M; Nyabi O; Elouennass M; El Fahime E; Touil N; Gala JL; Ennibi K
    Microbiol Resour Announc; 2023 Jun; 12(6):e0007723. PubMed ID: 37222607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk evaluation and mitigation strategies for newly detected SARS-CoV-2 Omicron BF.7 subvariant: A brief report.
    Nazmunnahar ; Ahmed I; Islam MR
    Health Sci Rep; 2023 Mar; 6(3):e1127. PubMed ID: 36875932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Efficacy of the Neutralizing Antibody Therapy Sotrovimab in Patients with SARS-CoV-2 Omicron BA.1 and BA.2 Subvariant Infections.
    Miyashita N; Nakamori Y; Ogata M; Fukuda N; Yamura A; Ishiura Y; Ito T
    Viruses; 2023 May; 15(6):. PubMed ID: 37376600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution melting analysis to discriminate between the SARS-CoV-2 Omicron variants BA.1 and BA.2.
    Koshikawa T; Miyoshi H
    Biochem Biophys Rep; 2022 Sep; 31():101306. PubMed ID: 35791375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and high-resolution computed tomography findings of 805 patients with mild or moderate infection from SARS-CoV-2 Omicron subvariant BA.2.
    Pan YN; Gu MY; Mao QL; Ruan XZ; Du XF; Gao X; Chen XQ; Li AJ
    Curr Med Imaging; 2023 Apr; ():. PubMed ID: 37170975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
    Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
    JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned?
    Roohani J; Keikha M
    World J Virol; 2022 Nov; 11(6):496-501. PubMed ID: 36483099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California.
    Lewnard JA; Hong VX; Patel MM; Kahn R; Lipsitch M; Tartof SY
    Nat Med; 2022 Sep; 28(9):1933-1943. PubMed ID: 35675841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of liver injury in SARS-CoV-2 Omicron variant- and Omicron subvariant-infected patients.
    Deng H; Mai Y; Liu H; Guan J
    Ann Hepatol; 2023; 28(1):100763. PubMed ID: 36182032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Identification of SARS-CoV-2 Omicron BA.5 Spike Mutation F486V in Clinical Specimens Using a High-Resolution Melting-Based Assay.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Kinoshita M; Kuriki M; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2.
    Basheer A; Zahoor I; Yaqub T
    PLoS One; 2023; 18(5):e0281159. PubMed ID: 37224159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75.
    Wang Q; Iketani S; Li Z; Guo Y; Yeh AY; Liu M; Yu J; Sheng Z; Huang Y; Liu L; Ho DD
    Cell Host Microbe; 2022 Nov; 30(11):1512-1517.e4. PubMed ID: 36108630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Omicron BA.2 Subvariant of SARS-CoV-2 Outcompetes BA.1 in Two Co-infection Cases.
    Gjorgjievska M; Mehandziska S; Stajkovska A; Pecioska-Dokuzovska S; Dimovska A; Durmish I; Ismail S; Pavlovska T; Stojchevska A; Amedi H; Andonova J; Nikolovska M; Velickovikj S; Mitrev Z; Kungulovski I; Kungulovski G
    Front Genet; 2022; 13():892682. PubMed ID: 35495156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.
    Beaudoin CA; Petsolari E; Hamaia SW; Hala S; Alofi FS; Pandurangan AP; Blundell TL; Chaitanya Vedithi S; Huang CL; Jackson AP
    Biochem Biophys Res Commun; 2023 Jul; 666():61-67. PubMed ID: 37178506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Subvariant BA.2 in a Single-Source Community Outbreak.
    Cheng VCC; Ip JD; Chu AWH; Tam AR; Chan WM; Abdullah SMU; Chan BPC; Wong SC; Kwan MYW; Chua GT; Ip P; Chan JMC; Lam BHS; To WK; Chuang VWM; Yuen KY; Hung IFN; To KKW
    Clin Infect Dis; 2022 Aug; 75(1):e44-e49. PubMed ID: 35271728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
    Parums DV
    Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2.
    Ohashi H; Hishiki T; Akazawa D; Kim KS; Woo J; Shionoya K; Tsuchimoto K; Iwanami S; Moriyama S; Kinoshita H; Yamada S; Kuroda Y; Yamamoto T; Kishida N; Watanabe S; Hasegawa H; Ebihara H; Suzuki T; Maeda K; Fukushi S; Takahashi Y; Iwami S; Watashi K
    Antiviral Res; 2022 Sep; 205():105372. PubMed ID: 35798223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.
    Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Characterization of AZD7442 (Tixagevimab-Cilgavimab) Neutralization of SARS-CoV-2 Omicron Subvariants.
    Roe TL; Brady T; Schuko N; Nguyen A; Beloor J; Guest JD; Aksyuk AA; Tuffy KM; Zhang T; Streicher K; Kelly EJ; Kijak GH
    Microbiol Spectr; 2023 Mar; 11(2):e0033323. PubMed ID: 36877050
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.